Evolus CEO sells 105K shares at $9.04 each

Evolus CEO David Moatazedi disclosed an open-market sale of 105,108 EOLS shares, leaving him with just under 500,000 shares directly held.

Rhea-AI Filing Summary

Evolus, Inc. (EOLS) reported that President and Chief Executive Officer David Moatazedi sold 105,108 shares of common stock on September 2, 2026, in an open-market transaction at a weighted average price of $9.04 per share. Following this sale, he directly holds 499,592 shares of Evolus common stock.

Insider Trade Summary

Net Seller: 105,108 shares

Net Sell 1 txn

Insider MOATAZEDI DAVID

Role See Remarks

Sold 105,108 shs ($950K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	105,108	$9.0385	$950K

Holdings After Transaction: Common Stock — 499,592 shares (Direct)

Footnotes (1)

1. F1. The shares were sold in multiple trades at prices ranging from $9.00 to $9.13. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Shares sold: 105,108 shares Weighted average sale price: $9.04 per share Price range of individual trades: $9.00–$9.13 per share +1 more

4 metrics

Shares sold 105,108 shares Common stock sale by CEO on September 2, 2026

Weighted average sale price $9.04 per share Open-market or private sale of common stock

Price range of individual trades $9.00–$9.13 per share Multiple trades comprising the reported sale

Shares held after transaction 499,592 shares CEO’s direct ownership following the sale

Key Terms

weighted average sale price, open market or private transaction, Form 4

3 terms

weighted average sale price financial

"The price reported above reflects the weighted average sale price."

open market or private transaction financial

"Sale in open market or private transaction"

Form 4 regulatory

"disclosed in a Form 4 insider transaction report"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did EOLS report for CEO David Moatazedi?

Evolus reported that CEO David Moatazedi sold 105,108 shares of common stock on September 2, 2026, in an open-market transaction at a weighted average price of $9.04 per share, leaving him with 499,592 shares directly held afterward.

At what price did the EOLS shares sell in this Form 4 transaction?

The reported weighted average sale price was $9.04 per share. A footnote explains that the shares were sold in multiple trades at prices ranging from $9.00 to $9.13 per share.

How many EOLS shares does the CEO hold after this reported sale?

After the September 2, 2026 sale, David Moatazedi directly holds 499,592 shares of Evolus common stock, as disclosed in the Form 4 filing.

Was the EOLS insider sale made under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not marked as being made under a trading plan, and the footnotes do not state that the sale was pursuant to a Rule 10b5-1 plan.

What does the Form 4 footnote say about the EOLS sale prices?

The footnote states the shares were sold in multiple trades at prices ranging from $9.00 to $9.13 per share, and that the reported price is the weighted average sale price. Full trade details are available upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/04/2026 - 07:05 PM EDT Accepted by SEC EDGAR 09/04/2026 - 07:04 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MOATAZEDI DAVID

(Last) (First) (Middle)

520 NEWPORT CENTER DR.

SUITE 1200

(Street)

NEWPORT BEACH CALIFORNIA 92660

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Evolus, Inc. [ EOLS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/02/2026		S		105,108	D	$9.0385(1)	499,592	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were sold in multiple trades at prices ranging from $9.00 to $9.13. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

President and Chief Executive Officer

	/s/ Jeffrey J. Plumer, as attorney-in-fact for David Moatazedi	09/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)